Sir Demis Hassabis has stepped down as CEO of Google DeepMind to become chair and Alphabet chief scientist, marking the end of an era for the London-based AI lab as control shifts closer to its US parent amid intense commercial rivalry.
Sir Demis Hassabis is stepping down as Google DeepMind CEO to become chair and Alphabet chief scientist. CTO Koray Kavukcuoglu will lead DeepMind, while veteran engineers Jeff Dean and Sanjay Ghemawat depart to launch a startup.
China celebrates a historic achievement with its first two homegrown Fields Medal winners, Wang Hong and Deng Yu. This marks the first time an Asian nation has produced two laureates in a single year, placing China among the top five countries globally to do so.
Google DeepMind CEO Demis Hassabis predicts Artificial General Intelligence (AGI) will emerge by 2030, calling it a "new human era." He believes 2026 was a turning point, with AI agents becoming useful. Others, like Elon Musk and Sam Altman, share similar timelines, while some argue current models already qualify as AGI. Skeptics point to benchmark failures, and a lack of a clear AGI definition complicates the debate.
Захар Прилепин рассказал, что Владимир Мединский заинтересован в создании альтернативы Нобелевской премии по литературе. Проект планируется реализовать поэтапно: сначала на территории СНГ, затем с вовлечением стран БРИКС и, наконец, на международном уровне.
Anthropic co-founder Jack Clark predicts AI will achieve Nobel-level discoveries in 12 months, help tradespeople via robots in two years, and generate millions via AI-run companies in 18 months. He also warned of existential risks.
Google DeepMind agrees to formal talks with UK unions CWU and Unite via Acas, potentially leading to trade union representation, amid staff concerns over AI use by US and Israeli defense and intelligence.
German Nobel laureate Hartmut Michel, 77, has joined Jilin University in Changchun, northeastern China as a full-time professor at the First Hospital. The 1988 Chemistry Nobel Prize winner will lead research in structural biology, drug development and translational medicine, and help train young scientists. The university described him as a flagship hire under its talent recruitment strategy.
